This site is intended for healthcare professionals
Patient with Hidradenitis suppurativa (HS)
Hidradenitis suppurativa (HS) Learning Zone
Declaration of sponsorship Novartis Pharma AG

EHSF 2024

Declaration of sponsorship Novartis Pharma AG
Last updated:12th Feb 2024
Published:12th Feb 2024

EHSF 2024: New directions for HS management in Europe

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Dermatology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Dermatology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Dermatology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Dermatology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Dermatology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Dermatology resources